| Infratil Limited (IFT) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$12,361 |
Infratil Newsletter - Impacts of the One Big Beautiful Bill
|
9 Jul 2025 9:41AM |
$9.990 |
$12.370 |
risen by
23.82%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$7 |
Change of Director's Interest Notice
|
9 Jul 2025 9:40AM |
$0.035 |
$0.046 |
risen by
31.43%
|
|
| Juno Minerals Limited (JNO) ORDINARY FULLY PAID |
Materials |
$5 |
Notice of General Meeting
|
9 Jul 2025 9:40AM |
$0.027 |
$0.026 |
fallen by
3.70%
|
|
| Challenger Gold Limited (CEL) ORDINARY FULLY PAID |
Materials |
$303 |
Final Testwork Underway Ahead of Full-Scale PFS
|
9 Jul 2025 9:38AM |
$0.081 |
$0.115 |
risen by
41.98%
|
|
CEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Final metallurgical testwork is in progress for the Hualilan Gold Project.
- Testwork results are key inputs for the upcoming full-scale Pre-Feasibility Study (PFS).
- Preliminary results confirm encouraging recoveries of gold, silver, and zinc.
- Optimization of processing flowsheets is a major focus of the testwork.
- The testwork will guide decisions on the most effective and efficient processing route.
- CEL has engaged experienced metallurgical consultants to oversee the testwork program.
- The outcome of the testwork will substantially inform the PFS and future project development.
- CEL is committed to progressing the Hualilan Gold Project towards production in a responsible manner.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$93 |
Notification regarding unquoted securities - AVH
|
9 Jul 2025 9:37AM |
$1.645 |
$1.085 |
fallen by
34.04%
|
|
| Perpetual Resources Limited (PEC) ORDINARY FULLY PAID |
Materials |
$18 |
Igrejinha Drilling Update Highlights Caesium Potential
|
9 Jul 2025 9:37AM |
$0.011 |
$0.017 |
risen by
54.55%
|
|
PEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Perpetual Resources Limited reported a successful caesium discovery at the Igrejinha Project in Brazil.
- Drilling intersected high-grade caesium mineralisation, primarily in the form of pollucite.
- The project has the potential to become a significant resource of caesium, a critical mineral for various industries.
- Results include thick and high-grade intervals of caesium, supporting further exploration.
- Geological assessments confirm the presence of caesium-bearing minerals and provide context for ongoing exploration.
- Detailed drilling methodologies and sampling procedures were described to support the resource definition process.
- Perpetual Resources intends to continue drilling and expand the resource base at Igrejinha.
- The project is well-positioned to contribute to the global caesium supply chain amid growing demand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$656 |
EUR Sells 0.5m CRML Shares for U$1.625m (A$2.5m)
|
9 Jul 2025 9:37AM |
$0.069 |
$0.380 |
risen by
450.72%
|
|
EUR - Price-sensitive ASX Announcement
Full Release
Key Points
- European Lithium Limited sold 500,000 shares of Critical Metals Corp (CRML) for US$1.625 million (A$2.5 million).
- The sale provides additional working capital to EUR.
- The transaction follows the recent NASDAQ listing of CRML.
- EUR is optimizing its asset portfolio to maximize shareholder value.
- Proceeds will support EUR’s ongoing lithium project developments.
- EUR retains a significant stake in CRML and will update shareholders on further decisions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| North Stawell Minerals Ltd (NSM) ORDINARY FULLY PAID |
Materials |
$11 |
Update - Proposed issue of securities - NSM
|
9 Jul 2025 9:32AM |
$0.042 |
$0.029 |
fallen by
30.95%
|
|
| Asian Investment Corporation Limited (ANV) ORDINARY FULLY PAID |
- |
- |
Appendix 3A.2 - Notification of interest payment
|
9 Jul 2025 9:31AM |
n/a |
n/a |
n/a
|
|
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$469 |
Colossus PFS Unlocks World-Class Project Economics
|
9 Jul 2025 9:31AM |
$0.515 |
$3.620 |
risen by
602.91%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Colossus Project PFS demonstrates world-class project economics with high margins and low operating costs.
- The project targets high-grade ionic adsorption clay (IAC) rare earth minerals in Brazil.
- Initial phase focuses on mining and beneficiation, producing monazite concentrate and mixed rare earth carbonate (MREC).
- Scalable modular development plan allows phased expansion to match market demand.
- The PFS anticipates strong financial performance, including rapid payback period and high internal rate of return (IRR).
- Significant exploration upside exists at Colossus, with opportunities to expand resources and extend mine life.
- Environmental, social, and governance (ESG) initiatives include renewable energy use, low water consumption, and community engagement.
- The project is strategically positioned to become a leading non-Chinese supplier of key rare earths required for electric vehicles, wind turbines, and other green technologies.
- Strong support from Brazilian authorities and favorable permitting environment.
- Viridis Mining and Minerals is well-funded to advance Colossus into the next stages of development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$111 |
Suspension from Quotation
|
9 Jul 2025 9:30AM |
$4.950 |
$23.550 |
risen by
375.76%
|
|
AII - Price-sensitive ASX Announcement
Full Release
Key Points
- Almonty Industries Inc. (AII) securities are suspended from quotation as of 5 June 2024.
- The suspension is due to the company's failure to lodge its periodic report by the prescribed deadline.
- The ASX Listing Rules require timely lodgment of periodic reports for continued quotation.
- If Almonty does not lodge the required report within five business days, its securities may be removed from quotation.
- The company may apply for removal from the official list if required.
- The announcement details ASX procedures and consequences for non-compliance with listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,078 |
Appendix 3Y - Rachel Wiseman
|
9 Jul 2025 9:29AM |
$4.520 |
$2.980 |
fallen by
34.07%
|
|
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$2,744 |
Application for quotation of securities - SRL
|
9 Jul 2025 9:25AM |
$1.030 |
$17.840 |
risen by
1,632.04%
|
|
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$26 |
Section 708A Cleansing Notice
|
9 Jul 2025 9:24AM |
$0.029 |
$0.011 |
fallen by
62.07%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$109 |
Investor presentation
|
9 Jul 2025 9:22AM |
$0.145 |
$0.370 |
risen by
155.17%
|
|
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$26 |
Application for quotation of securities - VHL
|
9 Jul 2025 9:22AM |
$0.029 |
$0.011 |
fallen by
62.07%
|
|
| NetLinkz Limited (NET) ORDINARY FULLY PAID |
Information Technology |
- |
Kognitive Networks Partners with NET and Securelink Networks
|
9 Jul 2025 9:21AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$546 |
Change of Director's Interest Notice
|
9 Jul 2025 9:20AM |
$3.320 |
$2.440 |
fallen by
26.51%
|
|
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$3 |
Company Update
|
9 Jul 2025 9:19AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anatara Lifesciences Ltd is developing gastrointestinal health products for human and animal markets.
- The company’s key products are GaRP (for human health) and 3FLEX (for animal health).
- Multiple pre-clinical and non-clinical studies have shown promising results.
- The company is actively pursuing regulatory submissions and commercial partnerships.
- Cash reserves and a lean cost structure place Anatara in a stable financial position to execute its strategy.
- ANR is focused on progressing licensing deals and market entry for both its human and animal health products.
- Strategic priorities include advancing regulatory approvals, expanding commercial relationships, and maximizing shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,078 |
Becoming a substantial holder
|
9 Jul 2025 9:19AM |
$4.520 |
$2.980 |
fallen by
34.07%
|
|
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$26 |
Application for quotation of securities - VHL
|
9 Jul 2025 9:19AM |
$0.029 |
$0.011 |
fallen by
62.07%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,107 |
Update - Notification of buy-back - GNC
|
9 Jul 2025 9:17AM |
$7.560 |
$4.980 |
fallen by
34.13%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$109 |
Portfolio expansion achieved with acquisition of Galidesivir
|
9 Jul 2025 9:16AM |
$0.145 |
$0.370 |
risen by
155.17%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals Limited acquired Galidesivir from BioCryst Pharmaceuticals.
- Galidesivir is a broad-spectrum antiviral with potential applications against multiple viral infections.
- The acquisition aligns with Island's strategy to expand its antiviral portfolio, especially targeting mosquito-borne diseases.
- Strategic rationale includes portfolio diversification, increased pipeline value, and enhanced market position in infectious disease therapeutics.
- The addition of Galidesivir is anticipated to provide new opportunities for clinical development and commercialization.
- The transaction underscores Island’s commitment to addressing global health challenges with innovative antiviral solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$48 |
Investor Presentation
|
9 Jul 2025 9:15AM |
$0.183 |
$0.044 |
fallen by
75.89%
|
|
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$4 |
Test work underway for rutile & gallium by-product potential
|
9 Jul 2025 9:15AM |
$0.079 |
$0.047 |
fallen by
40.51%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsland Minerals Ltd is conducting test work for rutile and gallium by-product potential at the Leliyn Graphite Project.
- ALS Metallurgy has been engaged for mineralogical and metallurgical studies on recent drill samples.
- Test work aims to assess the presence and recovery of rutile and gallium, which are classified as critical minerals.
- Positive results could add significant value to the graphite project.
- There is strong global demand for both rutile and gallium due to their strategic applications.
- Graphite resource and metallurgical studies are continuing in parallel to the by-product investigations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.